Ron Welch, PharmD, BCPS, BCIDP

Pharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.

Recent studies suggest limited benefit post-myocardial infarction for patients with preserved heart function, prompting potential updates to treatment guidelines and reconsideration of long-term use.

The BLING III trial investigated continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis, finding no significant difference in 90-day mortality but suggesting potential benefits in clinical cure rates.

The disease is complex, but many opportunities exist for pharmacist intervention.

Study results indicate early swap to oral antibiotics in Staphylococcus aureus bacteremia is just as effective.

SAB is a complicated disease state with a high mortality rate.

The RESCUE BT2 trial sheds further light on the agent’s potential.

Pharmacists need to ensure anticoagulants are held appropriately before and after surgery to prevent complications from for CIED infections.

Biomarkers are commonly used by physicians to assist in the earlier diagnosis of some of the most common fungal diseases.